CN105663446A - Drug for treating kidney cancer and preparation method - Google Patents
Drug for treating kidney cancer and preparation method Download PDFInfo
- Publication number
- CN105663446A CN105663446A CN201610108684.6A CN201610108684A CN105663446A CN 105663446 A CN105663446 A CN 105663446A CN 201610108684 A CN201610108684 A CN 201610108684A CN 105663446 A CN105663446 A CN 105663446A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- drug
- renal carcinoma
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 206010038389 Renal cancer Diseases 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 229940079593 drug Drugs 0.000 title abstract description 12
- 208000008839 Kidney Neoplasms Diseases 0.000 title abstract 2
- 201000010982 kidney cancer Diseases 0.000 title abstract 2
- 208000006265 Renal cell carcinoma Diseases 0.000 claims abstract description 39
- 201000010174 renal carcinoma Diseases 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241001149110 Limonium wrightii Species 0.000 claims abstract description 9
- 239000009526 Fructus Akebiae Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 241001062802 Adinandra millettii Species 0.000 claims description 8
- 241000237524 Mytilus Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 241000722953 Akebia Species 0.000 claims 3
- 239000008280 blood Substances 0.000 abstract description 36
- 210000004369 blood Anatomy 0.000 abstract description 33
- 208000024891 symptom Diseases 0.000 abstract description 23
- 210000004185 liver Anatomy 0.000 abstract description 17
- 206010030113 Oedema Diseases 0.000 abstract description 15
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 208000004880 Polyuria Diseases 0.000 abstract description 13
- 230000035619 diuresis Effects 0.000 abstract description 13
- 206010028980 Neoplasm Diseases 0.000 abstract description 11
- 208000008035 Back Pain Diseases 0.000 abstract description 10
- 208000008930 Low Back Pain Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 201000003872 goiter Diseases 0.000 abstract description 9
- 230000001939 inductive effect Effects 0.000 abstract description 8
- 230000002159 abnormal effect Effects 0.000 abstract description 6
- 238000001816 cooling Methods 0.000 abstract description 6
- 206010020772 Hypertension Diseases 0.000 abstract description 5
- 208000007502 anemia Diseases 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000003908 liver function Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 206010037660 Pyrexia Diseases 0.000 abstract description 2
- 241000543324 Adinandra Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 241001125690 Marsdenia tenacissima Species 0.000 abstract 1
- 241000736305 Marsilea quadrifolia Species 0.000 abstract 1
- 241000237536 Mytilus edulis Species 0.000 abstract 1
- 235000003174 Panax japonicus Nutrition 0.000 abstract 1
- 241000168720 Panax japonicus Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241001619444 Wolfiporia cocos Species 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 abstract 1
- 235000020638 mussel Nutrition 0.000 abstract 1
- 208000016261 weight loss Diseases 0.000 abstract 1
- 239000013585 weight reducing agent Substances 0.000 abstract 1
- 208000006750 hematuria Diseases 0.000 description 15
- 206010042674 Swelling Diseases 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 208000014674 injury Diseases 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 206010018498 Goitre Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000008736 traumatic injury Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 238000011084 recovery Methods 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 5
- 206010027514 Metrorrhagia Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 208000001780 epistaxis Diseases 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010003011 Appendicitis Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 208000028659 discharge Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000019206 urinary tract infection Diseases 0.000 description 4
- 239000002435 venom Substances 0.000 description 4
- 210000001048 venom Anatomy 0.000 description 4
- 231100000611 venom Toxicity 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010009168 Chyluria Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 235000019636 bitter flavor Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000005511 L01XE05 - Sorafenib Substances 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000008601 Polycythemia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000009800 partial cystectomy Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000009801 radical cystectomy Methods 0.000 description 1
- 208000026830 renal pelvis benign neoplasm Diseases 0.000 description 1
- 201000008946 renal pelvis neoplasm Diseases 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000011581 secondary neoplasm Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 229960003787 sorafenib Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a drug for treating kidney cancer and a preparation method and belongs to the field of traditional Chinese medicine. Effective components of the drug disclosed by the invention are the following raw materials: radix sanguisorbae, fructus akebiae, herba cardui crispi, herba scutellariae barbatae, radix salviae miltiorrhizae, herba salviae chinensis, marsdenia tenacissima, mussel, four-leaf clover, herba peperomiae dindygulensis, poria cocos, adinandra mellettii, herba galii teneri, kelp, limonium wrightii and panax japonicus. According to the drug disclosed by the invention, all the selected traditional Chinese drugs are properly matched and complement each other; the drug has the effects of cooling blood and stopping bleeding, clearing away heat and detoxifying, inducing diuresis to alleviate edema, softening hardness to dissipate stagnation, tonifying liver and kidney, benefiting life essence and blood, eliminating goiters and tumors, resisting cancers and the like; all the drugs are combined and the drug function directly reaches a diseased region; the drug has the advantages of rapid effect, high curing rate, and no toxic and side effects on symptoms including hematuresis, lumps, lumbago, weight reduction, fever, abnormal liver functions, anemia, hypertension and the like caused by renal carcinoma, and is safe and convenient, is low in price and easy to prepare, and is worthy of being widely popularized and applied clinically.
Description
Art
The present invention relates to the field of Chinese medicines, particularly relate to a kind of medicine treating renal carcinoma and preparation method.
Background technology
Renal carcinoma is initiated by the malignant tumor of excess of the kidney matter uriniferous tubule epithelial systems, and academic noun full name is renal cell carcinoma, also known as renal adenocarcinoma, referred to as renal carcinoma. Including the various renal cell carcinoma hypotypes originating from uriniferous tubule different parts, but do not include the tumor and the tumor of renal pelvis that derive from renal interstitial.
In the last few years, the asymptomatic renal carcinoma found when most of patients with renal cell carcinoma are due to Physical Examination, these patients accounted for more than the 50%-60% of patients with renal cell carcinoma sum. In Symptomatic patients with renal cell carcinoma, modal symptom is lumbago and hematuria, and small number of patients is to come institute with abdominal mass to go to a doctor. There is secondary tumor syndrome in the patient of 10%-40%, and show as hypertension, anemia, lose weight, cachexia, heating, erythrocytosis, abnormal liver function, hypercalcemia, hyperglycemia, erythrocyte sedimentation rate speed, neuromuscular pathological changes, amyloidosis, galactorrhea disease, clotting mechanism are abnormal etc. changes. The patient of 20%-30% can the symptom such as osteodynia caused by neoplasm metastasis, fracture, cough, spitting of blood go to a doctor.
A lot of people can cause suffering from renal carcinoma because not noting daily health care, and the appearance of renal carcinoma is very fearful, and the injury of human body is very big, and patient to be also subject to certain torment in spirit. If we treat not in time, the consequence caused also is very serious.
At present, operative treatment is the essential therapeutic arsenals of renal carcinoma, specifically include that underwent transurethral resection of bladder tumor (TURBT), Bladder stone Excision of bladder tumour (HOLRBT), partial cystectomy and radical cystectomy etc., but postoperative easy recurrence, patient suffering is big. For this, we are badly in need of developing a kind of medicine to help patient to break away from the misery that renal carcinoma is brought.
Summary of the invention
The invention provides a kind of medicine treating renal carcinoma and preparation method; Selected by medicine of the present invention, medical material compatibility is suitable, bring out the best in each other, and there is cooling blood for hemostasis, heat-clearing and toxic substances removing, inducing diuresis to remove edema, hard masses softening and resolving, invigorating the liver and kidney, benefiting essence-blood, the goiter that disappears, the effect such as anticancer, all medicines are harmonious the through diseased region of drug effect, hematuria that renal carcinoma is caused, lump, lumbago, lose weight, generate heat, symptom has instant effect, cure rate is high for abnormal liver function, anemia, hypertension etc., have no side effect, the advantage of safe ready, and low price, easily preparation, wide popularization and application on clinic.
For achieving the above object, technical scheme is implemented as follows:
A kind of medicine treating renal carcinoma, make described effective ingredient raw material composition and parts by weight be:
Make described effective ingredient raw material composition and parts by weight be:
Make described effective ingredient raw material composition and parts by weight be:
Make described effective ingredient raw material composition and parts by weight be:
The preparation method of a kind of medicine treating renal carcinoma, comprises the following steps that:
(1) Radix Sanguisorbae, Herba Salviae Chinensis and Herba Galii Teneri are twisted juice, filter impurity, stay juice, standby;
(2) Fructus Akebiae, Herba Cardui Crispi, Herba Peperomiae Dindygulensis and ring are participated in 10 times amount volumetric concentration 70% alcoholic solution extract three times, each 3 hours, filter, merging filtrate, place overnight, reclaim ethanol and to be concentrated into the dope that 60 DEG C of relative densities are 1.12-1.151 standby;
(3) Herba Scutellariae Barbatae, Radix Salviae Miltiorrhizae, Mytilus, Herba Galii Bungei, Poria, Adinandra millettii, Thallus Laminariae (Thallus Eckloniae) and Limonium wrightii Kuntz are put in container, add distilled water and boil extraction 3 times, add 10-15 times amount distilled water immersion first 4-5 hour, heated and boiled 3-4 hour, extract; Second time adds 8-10 times amount distilled water heated and boiled 2-3 hour, extracts; Third time adds 6-8 times amount distilled water heated and boiled 1-2 hour, extracts; Merge three extracting solution, filter, obtain filtrate, be condensed into dry extract standby; It is 90% alcoholic solution that dry extract adds volumetric concentration, stands, is extracted by supernatant, and the extractum precipitated is standby;
(4) by Caulis Marsdeniae Tenacissimae microwave drying, grind into powder, obtained the fine powder of 180 orders, standby;
(5) juice, dope, extractum and the fine powder mixing that step (1)-step (4) prepares, makes tablet, is the medicine of described treatment renal carcinoma.
The property of medicine of Chinese medicine used by the present invention is as follows:
Radix Sanguisorbae: bitter in the mouth, acid, cold in nature; Return liver, lung, kidney, large intestine channel. Cooling blood for hemostasis, heat-clearing and toxic substances removing, sore of subsiding a swelling. Main haematemesis, spitting of blood, epistaxis, hematuria, have blood in stool, hemorrhoidal bleeding, dysentery, metrorrhagia, leucorrhea with red and white discharge, sore, carbuncle and painful swelling, eczema, pudendal pruritus, burn due to hot liquid or fire, snake bite and insect sting. " not Lu " load: " only pus and blood, all flaccidity, malignant boil, disappear wine, except quenching one's thirst, mends wound absolutely, and in puerperal, plug, can make incised wound cream. Main internal hemorrhage due to trauma is more than, insufficiency of blood. "
Fructus Akebiae: mildly bitter flavor, property is put down; Return liver, stomach, bladder warp. Dispersing the stagnated liver-QI for regulating the stomach, promoting blood circulation and stopping pain, hard masses softening and resolving, diuresis. Main stagnation of liver-QI and stomach-QI, gastral cavity abdomen, the side of body help distending pain, and diet does not disappear, and dysentery is just let out, hernia pain, lumbago, amenorrhea dysmenorrhea, goiter scrofula, malignant tumor. " Traditional Chinese Medicine in Sichuan will " carries: " soothing the liver, receive kidney qi. Control bladder hernia, spit blood. "
Herba Cardui Crispi: mildly bitter flavor, cool in nature. Expelling wind and clearing away heat, dampness removing, cooling blood for hemostasis, promoting blood circulation and detumescence. Main cold cough, dizziness of having a headache, urinary system infection, chyluria, leucorrhea, jaundice, rheumatic arthralgia, spit blood, epistaxis, hematuria, menorrhagia, dysfunctional uterine hemorrhage, traumatic injury, furuncle furuncle and phyma, swelling and pain of hemorrhoid, burn. Soviet Union doctor " Chinese herbal medicine handbook " load: " dispel the wind, dampness removing, heat clearing away, detumescence. Control chyluria, hematuria, urinary tract infection, influenza, leukorrhagia, menorrhagia; External curing pyogenic infections from tumour or sore, swelling and pain of hemorrhoid. "
Herba Scutellariae Barbatae: acrid in the mouth, hardship, cold in nature; Return lung, liver, kidney channel. Heat-clearing and toxic substances removing, dissipating blood stasis stops blooding, inducing diuresis to remove edema. Main pyretic toxicity carbuncle, has sore throat, lung abscess, acute appendicitis, scrofula, venom, traumatic injury, spits blood, epistaxis, stranguria with blood, edema, ascites and cancer.Guangzhou army " conventional Chinese herbal medicine handbook " load: " heat-clearing and toxic substances removing. For cancer see the effect improving symptom; Appendicitis, hepatitis. "
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, pericardium, Liver Channel. Blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving, nourishing blood to tranquillize the mind, removing heat from blood eliminating carbuncle. Main menoxenia, dysmenorrhea, amenorrhea, puerperal the stagnant stomachache of the stasis of blood, trusted subordinate's pain, lump in the abdomen, pyretic arthralgia swells and ache, traumatic injury, and heat enters nutrient blood, dysphoria, vexed insomnia, ulcerative carbuncle toxic swelling. " Japan hanako materia medica " carries: " sedate of reposing, tonneau GUAN-pulse. Controlling cold and hot labor, arthralgia, extremity are unsuccessful; Evacuation of pus pain relieving, granulation promoting is put on flesh; Broken stagnated blood, mends new hemopoietic; Peaceful tire, fall stillborn fetus; Under hemostasis metrorrhagia and leukorrhagia, adjusting married woman's passages through which vital energy circulates irregular, blood evil thought is tired of; Malignant boil scabies, wart is gone to live in the household of one's in-laws on getting married toxic swelling, erysipelas; Headache, acute conjunctivitis, heat temperature is mad vexed. "
Herba Salviae Chinensis: acrid in the mouth, hardship, cold nature; Return liver, spleen channel. Blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, mass dissipating and swelling eliminating. Main menoxenia, dysmenorrhea, amenorrhea, metrorrhagia, have blood in stool, jaundice due to damp-heat, hot toxic-heat and blood stasis, drench pain, leukorrhagia, rheumatic ostalgia, scrofula, skin ulcer swells, acute mastitis, herpes zoster, leprosy, and traumatic injury wound is swollen. " detailed outline " carries: " main osteodynia, strong wind, carbuncle. "
Caulis Marsdeniae Tenacissimae: bitter in the mouth, cold nature; Return lung, Liver Channel. Heat-clearing and toxic substances removing, relieving cough and asthma, tonneau wets lactogenesis, does cancer. Main laryngopharynx swelling and pain, lung-heat cough with asthma, jaundice due to damp-heat, dysuria, galactostasis, furuncle, cancerous protuberance. " choosing of Yunnan Chinese herbal medicine " carries: " antiinflammatory, cough-relieving are relievingd asthma, anticancer. Control bronchitis, bronchial asthma, various cancers, rheumatism, traumatic injury, fracture, optical fundus illness, gastropathy. "
Mytilus: sweet in the mouth, salty, warm in nature; Return liver, kidney channel. Invigorating the liver and kidney, benefiting essence-blood, disappear goiter. Main asthenia weakness and emaciation, dizziness, night sweat, sexual impotence, lumbago, spit blood, metrorrhagia, leukorrhagia, goiter. " occupying diet spectrum with breath " load: " the kidney invigorating, benefit blood replenishing essence are controlled something lost, are with, collapse, are drenched, and sexual impotence is sombre, quenches one's thirst, goiter. "
Herba Galii Bungei: sweet in the mouth, hardship, property is put down; Return liver, spleen channel. Clearing away heat and promoting diuresis, removing toxic substances and promoting subsidence of swelling. Main urinary tract infection, cancerous protuberance, leucorrhea with red and white discharge, dysentery, carbuncle, traumatic injury, hemoptysis, women's leucorrhea with red and white discharge, infantile malnutrition, carbuncle furunculosis, venom. Soviet Union doctor " Chinese herbal medicine handbook " load: " inducing diuresis to remove edema, anticancer. Control urinary tract infection, leucorrhea with red and white discharge, cervical erosion, suppurative inflammation. And control cerebrospinal meningitis, septic septicemia, carbuncle, venom, skin sore edema, cancerous protuberance. "
Herba Peperomiae Dindygulensis: acrid in the mouth, cool in nature; Return lung, spleen, liver, kidney channel. Heat-clearing and toxic substances removing, blood stasis-eliminating and stagnation-dissipating, inducing diuresis to remove edema. Main lung-heat cough with asthma, measles, sore, cancerous protuberance, burn and scald, traumatic injury, oedema due to nephritis. " choosing of Yunnan Chinese herbal medicine " load load: " eliminating stasis and resolving masses, anticancer. Control gastric cancer, esophageal carcinoma, hepatocarcinoma, breast carcinoma, pulmonary carcinoma. "
Poria: sweet in the mouth, light, property is put down; GUIXIN, spleen, lung, kidney channel. Eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming. Main dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, insufficiency of the spleen lack of appetite, have loose bowels, palpitation and restlessness, insomnia forgetfulness, nebulousurine of passing out semen. " not Lu " load: " only quench one's thirst, like to sleep, big abdomen, drench drop, the disease due to obstruction of QI of middle-JIAO expectorant water, edema drenches knot. Opening breast internal organs, adjust visceral-qi, cut down kidney heresy, long the moon, physical strength profiting, during guarantor god keeps. " modern medicine study confirmation, this product has antitumor action.
Adinandra millettii: bitter in the mouth, cool in nature;Return lung, Liver Channel. Cooling blood for hemostasis, removing toxic substances and promoting subsidence of swelling. Main epistaxis, hematuria, infectious hepatitis, parotitis, furuncle and phyma, snake bite and insect sting, cancerous protuberance.
Herba Galii Teneri: acrid in the mouth, micro-hardship, cold nature; Return Shao Yin, Taiyin channels. Heat-clearing and toxic substances removing, inducing diuresis for treating stranguria syndrome, reducing swelling and alleviating pain. Main swollen ulcer drug, mastitis, appendicitis, edema, cold, fever, dysentery, urinary tract infection, hematuria, gingival hemorrhage, knife injury is hemorrhage. Jiangxi " medical herbs handbook " is carried: " heat-clearing and toxic substances removing, reducing swelling and alleviating pain. Controlling carbuncle, appendicitis, closely for for cancer. " clinical trial proves, this product has the effect for the treatment of tumor.
Thallus Laminariae (Thallus Eckloniae): salty in the mouth, cold in nature; Return liver, stomach, kidney, spleen channel. Eliminating phlegm and softening indurated mass, diuretic detumescent. Main scrofula, goiter, dysphagic, (Epileptic is ruined) hernia beriberi edema. " beautiful Chinese catalpa medicine solution " load: " sluicing is dried, removing mass softening the hard mass. Clearing away heat and promoting diuresis, controls flatulence watery distension, scrofula goiter, and TUI hernia malignant boil, with Sargassum, the same merit of Thallus Laminariae (Thallus Eckloniae). "
Limonium wrightii Kuntz: lightly seasoned, cool in nature; Inducing diuresis to remove edema. Main edema.
Rhizoma Panacis Japonici: sweet in the mouth, micro-hardship, slightly warm in nature; Return lung, spleen, Liver Channel. Xu-tonic, eliminating phlegm and stopping cough, dissipating blood stasis stops blooding, reducing swelling and alleviating pain. Main weak after being ill, inappetence, cough due to consumptive disease, spitting of blood, spit blood, epistaxis, to have blood in stool, hematuria, vicarious menstruation, metrorrhagia, traumatic hemorrhage, lump in the abdomen, blood stasis amenorrhea, puerperal, stasis of blood the moon was suffered from abdominal pain, traumatic injury, rheumatic arthritis, carbuncle, hemorrhoid, venom.
The present invention compared with prior art, has the advantages that
Selected by medicine of the present invention, medical material compatibility is suitable, bring out the best in each other, and there is cooling blood for hemostasis, heat-clearing and toxic substances removing, inducing diuresis to remove edema, hard masses softening and resolving, invigorating the liver and kidney, benefiting essence-blood, the goiter that disappears, the effect such as anticancer, all medicines are harmonious the through diseased region of drug effect, hematuria that renal carcinoma is caused, lump, lumbago, lose weight, generate heat, symptom has instant effect, cure rate is high for abnormal liver function, anemia, hypertension etc., have no side effect, the advantage of safe ready, and low price, easily preparation, wide popularization and application on clinic.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further elaborated.
Embodiment 1
The raw material of effective ingredient of the present invention forms and weight is:
The processing step of process for preparing medicine of the present invention is:
(1) Radix Sanguisorbae, Herba Salviae Chinensis and Herba Galii Teneri are twisted juice, filter impurity, stay juice, standby;
(2) Fructus Akebiae, Herba Cardui Crispi, Herba Peperomiae Dindygulensis and ring are participated in 10 times amount volumetric concentration 70% alcoholic solution extract three times, each 3 hours, filter, merging filtrate, place overnight, reclaim ethanol and to be concentrated into the dope that 60 DEG C of relative densities are 1.12-1.151 standby;
(3) Herba Scutellariae Barbatae, Radix Salviae Miltiorrhizae, Mytilus, Herba Galii Bungei, Poria, Adinandra millettii, Thallus Laminariae (Thallus Eckloniae) and Limonium wrightii Kuntz are put in container, add distilled water and boil extraction 3 times, add 10-15 times amount distilled water immersion first 4-5 hour, heated and boiled 3-4 hour, extract; Second time adds 8-10 times amount distilled water heated and boiled 2-3 hour, extracts; Third time adds 6-8 times amount distilled water heated and boiled 1-2 hour, extracts; Merge three extracting solution, filter, obtain filtrate, be condensed into dry extract standby; It is 90% alcoholic solution that dry extract adds volumetric concentration, stands, is extracted by supernatant, and the extractum precipitated is standby;
(4) by Caulis Marsdeniae Tenacissimae microwave drying, grind into powder, obtained the fine powder of 180 orders, standby;
(5) juice, dope, extractum and the fine powder mixing that step (1)-step (4) prepares, makes tablet, is the medicine of described treatment renal carcinoma.
Usage and dosage: oral, every day 3 times, each 3,15 days be a course for the treatment of, and 3 to 5 courses for the treatment of can fully recover, and the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
Embodiment 2
The raw material of effective ingredient of the present invention forms and weight is:
The process for preparing medicine processing step of the present embodiment and usage and dosage and embodiment 1 are identical.
Embodiment 3
The raw material of effective ingredient of the present invention forms and weight is:
The process for preparing medicine processing step of the present embodiment and usage and dosage and embodiment 1 are identical.
Embodiment 4
The raw material of effective ingredient of the present invention forms and weight is:
The process for preparing medicine processing step of the present embodiment and usage and dosage and embodiment 1 are identical.
Clinical data:
1, case selection:
As the medicine for the treatment of renal carcinoma, selecting the patients with renal cell carcinoma 336 example clinical observation that my institute or outer court make a definite diagnosis, patient is randomly divided into two groups, treatment group 168 example, wherein male 84 example, women 84 example, age 27-70 year, 46.8 years old mean age, course of disease 1-8; Matched group 168 example, wherein male 84 example, women 84 example, age 25-70 year, 45.4 years old mean age, course of disease 1-5. The course of disease of two groups of cases, degrees of symptoms are basically identical, without significant difference, have comparability.
2, medicament selection:
Treatment group patient takes medicine of the present invention, every day 3 times, each 3, and warm water delivery service in half an hour after meal 15 days is a course for the treatment of, takes 3 to 5 courses for the treatment of continuously, and the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
Matched group uses Sorafenib, by specification use, and the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
3, efficacy determination:
(1) cure: hematuria, lump, lumbago, lose weight, generate heat, the renal carcinoma transference cure such as abnormal liver function, anemia, hypertension, physical recovery is normal.
(2) effective: above-mentioned symptom is alleviated to some extent.
(3) invalid: disease is unchanged.
4, result:
Taking in the treatment group of medicine of the present invention, cure 118 examples, effective 47 examples, invalid 3 examples, cure rate is 70.2%, total effective rate 98.2%.
Curing 50 examples, effective 48 examples, invalid 70 examples in matched group, cure rate is 29.8%, total effective rate 58.3%.
Result above shows, the cure rate for the treatment of group and total effective rate are apparently higher than matched group.
Model case is illustrated:
1, Hu, man, 69 years old, retired worker, Sichuan Ziyang Man. There is hematuria, lump, lumbago shape without obvious inducement in patient, does not take a favorable turn in local hospital treatment. To our hospital for this, it is diagnosed as renal carcinoma on inspection. After taking 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom is clearly better; Continuing to take 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom all disappears, recovery from illness, follows up a case by regular visits to, does not recur.
2, certain is thanked, man, 52 years old, it is engaged in agriculture, people from Jilin, northeast. Patient was diagnosed as renal carcinoma before 2 years, occurred that tired, xerostomia is intended to drink, discomfort uncomfortable in chest, chest pain catch cropping, coughs the symptoms such as vomiting pus expectorant, constipation with dry stool, frequent micturition, dysurea, hematuria. To our hospital, take 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom is clearly better; Continuing to take 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom disappears, recovery from illness, follows up a case by regular visits to, does not recur.
3, certain is tried to gain, female, 44 years old, housewife, Linfen, Shanxi people. Patient suffers from renal carcinoma more than 2 years, the symptom such as hematuria, lump, lumbago occur, lose weight, and does not take an evident turn for the better after local hospital is treated. Introduce to our hospital by friend. After taking 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom starts to take a turn for the better;After continuing to take 3 courses for the treatment of of medicine of the present invention, above-mentioned symptom disappears, recovery from illness, follows up a case by regular visits to, does not recur.
4, Zhang, man, 38 years old, self-employed entrepreneurs, Baiyin people. Patient suffers from renal carcinoma more than 1 year, does not once take an evident turn for the better after multiple hospitals gives Drug therapy, introduces to our hospital by local doctor. Taking 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom takes a turn for the better; After continuing to take 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom disappears, recovery from illness, follows up a case by regular visits to, does not recur.
5, Zheng, man, 33 years old, supervisor, Liaoning people from Huludao City. Patient was diagnosed as renal carcinoma before 3 years, had carried out renal carcinoma ablation, after hematuria, dysurea symptom occur, check and find recurrence. For asking further diagnosis and treatment to our hospital. After taking 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom takes a turn for the better; Continuing to take 3 courses for the treatment of of medicine of the present invention, above-mentioned symptom disappears, recovery from illness, follows up a case by regular visits to, does not recur.
6, high certain, female, 28 years old, make up artist, people from Cangzhou, Hebei. There is hematuria, dysurea, lumbago shape in patient. Then arrive local hospital to go to a doctor, be diagnosed as renal carcinoma, do not take an evident turn for the better after giving Drug therapy. For asking further diagnosis and treatment to our hospital. Taking 2 courses for the treatment of of medicine of the present invention, above-mentioned symptom takes a turn for the better; Continuing to take medicine of the present invention, after 2 courses for the treatment of, above-mentioned symptom disappears, and recovery from illness is followed up a case by regular visits to, do not recurred.
Claims (5)
1. the medicine treating renal carcinoma, it is characterised in that: make described effective ingredient raw material composition and parts by weight be:
Radix Sanguisorbae 37-69 part Fructus Akebiae 33-65 part Herba Cardui Crispi 33-65 part Herba Scutellariae Barbatae 31-63 part
Radix Salviae Miltiorrhizae 29-61 part Herba Salviae Chinensis 29-61 part Caulis Marsdeniae Tenacissimae 27-51 part Mytilus 27-51 part
Herba Galii Bungei 25-49 part Herba Peperomiae Dindygulensis 25-49 part Poria 24-45 part Adinandra millettii 24-45 part
Herba Galii Teneri 23-43 part Thallus Laminariae (Thallus Eckloniae) 22-42 part Limonium wrightii Kuntz 20-40 part Rhizoma Panacis Japonici 18-30 part.
2. a kind of medicine treating renal carcinoma according to claim 1, it is characterised in that: make described effective ingredient raw material composition and parts by weight be:
62 parts of Fructus Akebiaes of Radix Sanguisorbae, 57 portions of Herba Scutellariae Barbataes of 57 parts of Herba Cardui Crispi 55 parts
53 parts of Herba Salviae Chinensiss of Radix Salviae Miltiorrhizae, 45 portions of Mytilus of 53 parts of Caulis Marsdeniae Tenacissimaes 45 parts
43 parts of Herba Peperomiae Dindygulensiss of Herba Galii Bungei, 40 parts of Adinandra millettii of 43 parts of Poria 40 parts
38 parts of Thallus Laminariae (Thallus Eckloniae)s of Herba Galii Teneri, 35 parts of Rhizoma Panacis Japonicis of 37 parts of Limonium wrightii Kuntz 27 parts.
3. a kind of medicine treating renal carcinoma according to claim 1, it is characterised in that: make described effective ingredient raw material composition and parts by weight be:
55 parts of Fructus Akebiaes of Radix Sanguisorbae, 49 portions of Herba Scutellariae Barbataes of 49 parts of Herba Cardui Crispi 47 parts
45 parts of Herba Salviae Chinensiss of Radix Salviae Miltiorrhizae, 39 portions of Mytilus of 45 parts of Caulis Marsdeniae Tenacissimaes 39 parts
37 parts of Herba Peperomiae Dindygulensiss of Herba Galii Bungei, 35 parts of Adinandra millettii of 37 parts of Poria 35 parts
33 parts of Thallus Laminariae (Thallus Eckloniae)s of Herba Galii Teneri, 30 parts of Rhizoma Panacis Japonicis of 32 parts of Limonium wrightii Kuntz 24 parts.
4. a kind of medicine treating renal carcinoma according to claim 1, it is characterised in that: make described effective ingredient raw material composition and parts by weight be:
47 parts of Fructus Akebiaes of Radix Sanguisorbae, 41 portions of Herba Scutellariae Barbataes of 41 parts of Herba Cardui Crispi 39 parts
37 parts of Herba Salviae Chinensiss of Radix Salviae Miltiorrhizae, 33 portions of Mytilus of 37 parts of Caulis Marsdeniae Tenacissimaes 33 parts
31 parts of Herba Peperomiae Dindygulensiss of Herba Galii Bungei, 30 parts of Adinandra millettii of 31 parts of Poria 30 parts
28 parts of Thallus Laminariae (Thallus Eckloniae)s of Herba Galii Teneri, 25 parts of Rhizoma Panacis Japonicis of 27 parts of Limonium wrightii Kuntz 21 parts.
5. the preparation method of the medicine of the treatment renal carcinoma as described in any one of claim 1-4, it is characterised in that: comprise the following steps that:
(1) Radix Sanguisorbae, Herba Salviae Chinensis and Herba Galii Teneri are twisted juice, filter impurity, stay juice, standby;
(2) Fructus Akebiae, Herba Cardui Crispi, Herba Peperomiae Dindygulensis and ring are participated in 10 times amount volumetric concentration 70% alcoholic solution extract three times, each 3 hours, filter, merging filtrate, place overnight, reclaim ethanol and to be concentrated into the dope that 60 DEG C of relative densities are 1.12-1.151 standby;
(3) Herba Scutellariae Barbatae, Radix Salviae Miltiorrhizae, Mytilus, Herba Galii Bungei, Poria, Adinandra millettii, Thallus Laminariae (Thallus Eckloniae) and Limonium wrightii Kuntz are put in container, add distilled water and boil extraction 3 times, add 10-15 times amount distilled water immersion first 4-5 hour, heated and boiled 3-4 hour, extract; Second time adds 8-10 times amount distilled water heated and boiled 2-3 hour, extracts; Third time adds 6-8 times amount distilled water heated and boiled 1-2 hour, extracts; Merge three extracting solution, filter, obtain filtrate, be condensed into dry extract standby; It is 90% alcoholic solution that dry extract adds volumetric concentration, stands, is extracted by supernatant, and the extractum precipitated is standby;
(4) by Caulis Marsdeniae Tenacissimae microwave drying, grind into powder, obtained the fine powder of 180 orders, standby;
(5) juice, dope, extractum and the fine powder mixing that step (1)-step (4) prepares, makes tablet, is the medicine of described treatment renal carcinoma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610108684.6A CN105663446A (en) | 2016-02-27 | 2016-02-27 | Drug for treating kidney cancer and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610108684.6A CN105663446A (en) | 2016-02-27 | 2016-02-27 | Drug for treating kidney cancer and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105663446A true CN105663446A (en) | 2016-06-15 |
Family
ID=56306170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610108684.6A Pending CN105663446A (en) | 2016-02-27 | 2016-02-27 | Drug for treating kidney cancer and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105663446A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106074851A (en) * | 2016-08-03 | 2016-11-09 | 解颖 | A kind of Chinese medicine composition is used for the application treating in the medicine of renal carcinoma in preparation |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189287A (en) * | 2014-09-15 | 2014-12-10 | 秦银忠 | Traditional Chinese medicine preparation for treating kidney cancer, and preparation method of traditional Chinese medicine preparation |
CN104825909A (en) * | 2015-06-04 | 2015-08-12 | 孙长发 | TCM (traditional Chinese medicine) preparation for renal cancer and preparing method thereof |
-
2016
- 2016-02-27 CN CN201610108684.6A patent/CN105663446A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189287A (en) * | 2014-09-15 | 2014-12-10 | 秦银忠 | Traditional Chinese medicine preparation for treating kidney cancer, and preparation method of traditional Chinese medicine preparation |
CN104825909A (en) * | 2015-06-04 | 2015-08-12 | 孙长发 | TCM (traditional Chinese medicine) preparation for renal cancer and preparing method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106074851A (en) * | 2016-08-03 | 2016-11-09 | 解颖 | A kind of Chinese medicine composition is used for the application treating in the medicine of renal carcinoma in preparation |
CN106074851B (en) * | 2016-08-03 | 2019-08-09 | 黑龙江中医药大学 | A kind of Chinese medicine composition is preparing the application in the drug for treating kidney |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101716318B (en) | Traditional Chinese medicine preparation for treating tumor of digestive system | |
CN103860843B (en) | One treats psoriasic Chinese medicine ointment and preparation method | |
CN103463494B (en) | One treats hypertensive Chinese medicine preparation | |
CN101590176B (en) | Chinese medicinal preparation for treating esophagus cancer | |
CN103417911B (en) | Traditional Chinese medicine composition for supporting chemo-treatment | |
CN102940808A (en) | Prescription medicine for treating lung cancer and preparation method | |
CN105663446A (en) | Drug for treating kidney cancer and preparation method | |
CN103893603B (en) | The medicine of a kind of therapeutic radiation rectitis and preparation method | |
CN103893562B (en) | A kind of medicine and preparation method for the treatment of otitis externa | |
CN113082168A (en) | Pharmaceutical composition for treating lung cancer and application thereof | |
CN103705655B (en) | Traditional Chinese medicine preparation for treating uterine cervicitis | |
CN103800890B (en) | A kind of medicine and preparation method for the treatment of menoxenia | |
CN103735999B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of gout | |
CN106177660A (en) | A kind of Chinese medicine preparation for treating hepatocarcinoma and preparation method | |
CN105770083A (en) | Traditional Chinese medicine preparation for treating rectal cancer | |
CN105617099A (en) | Medicine for treating adverse reactions caused by tumor chemotherapy and preparation method | |
CN104306796A (en) | Traditional Chinese medicine combination for relieving thyroid cancer postoperative liver depression phlegm stagnation syndrome | |
CN104547450A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method thereof | |
CN105031441A (en) | Medicine for treating ankylosing spondylitis and preparation method of medicine | |
CN104324339B (en) | A kind of medicine and preparation method being used for the treatment of and nursing menoxenia | |
CN104645112A (en) | Nasopharyngeal carcinoma hard mass softening and phlegm eliminating preparation and preparation method thereof | |
CN105998861A (en) | Medicine for treating gallstone and preparation method of medicine | |
CN113521177A (en) | Chinese medicine for treating tumor and preventing canceration | |
CN103735848B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of hyperosteogeny | |
CN103690902A (en) | Traditional Chinese medicinal preparation for preventing radiation side reactions of nasopharynx cancer chemoradiotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160615 |